IP Library Granted Patent US 8,476,292
Granted Patent B2
US 8,476,292 · App. 11/991,663 · Granted Jul 2, 2013

Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,476,292
App. No.
11/991,663
Granted
Jul 2, 2013
Kind
B2
Abstract

Amide and carbamate derivatives N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide, pharmaceutical compositions containing these compounds, methods of making the compounds, and methods of use of these compounds in modulating the immune system, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

Claims (16)

1. A compound of the Formula I

wherein:

Y is selected from the group consisting of —C(O)— and —C(O)—O—; and

R is selected from the group consisting of alkyl, aryl, and arylalkylenyl; wherein aryl and arylalkylenyl are unsubstituted or substituted by one or more substituents selected from the group consisting of alkyl, alkoxy, aryl, and halogen or a pharmaceutically acceptable salt thereof.

2. The compound or salt of claim 1 wherein Y is —C(O)—.

3. The compound or salt of claim 1 wherein Y is —C(O)—O—.

4. The compound or salt of claim 1 wherein R is alkyl, aryl, or arylalkylenyl.

5. The compound or salt of claim 4 wherein R is C 1-10 alkyl.

6. The compound or salt of claim 5 wherein R is C 1-5 alkyl.

7. The compound or salt of claim 6 wherein R is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, and tert-butyl.

8. The compound or salt of claim 4 wherein R is aryl.

9. The compound or salt of claim 8 wherein R is phenyl.

10. The compound or salt of claim 4 wherein R is arylalkylenyl.

11. The compound or salt of claim 10 wherein R is benzyl.

12. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 1 and a pharmaceutically acceptable carrier.

13. A method of inducing the biosynthesis of at least one of interferon-alpha or tumor necrosis factor-alpha in an animal comprising administering an effective amount of a compound or salt of claim 1 to the animal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2011
From: KSHIRSAGAR, TUSHAR A.; NIWAS, SHRI; MERRILL, BRYON A.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 026201/0306 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2010
From: COLEY PHARMACEUTICAL GROUP, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 025480/0574 →